Enzalutamide and Indomethacin in Treating Patients With Recurrent or Metastatic Hormone-Resistant Prostate Cancer

NCT02935205 · clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
UNKNOWN
Status
38
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Mamta Parikh

Collaborators